Related Experiment Video
Updated: May 29, 2026

Human iPSC-Derived Cardiomyocyte Networks on Multiwell Micro-electrode Arrays for Recurrent Action Potential Recordings
Published on: July 15, 2019
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action
Junyi Ma1, Liang Guo, Steve J Fiene
1Cellular Dynamics International, Madison, Wisconsin, USA.
Insights
Human-induced pluripotent stem cells (hiPSCs) yield cardiomyocytes with electrophysiological properties similar to human cells. These cells are valuable for drug screening and cardiovascular research due to their characteristics and potential for high-throughput assays.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Electrophysiology
Background:
- Human-induced pluripotent stem cells (hiPSCs) can differentiate into cardiomyocytes.
- Comprehensive electrophysiological characterization of hiPSC-derived cardiomyocytes is lacking.
- Understanding these properties is crucial for their application in research and therapy.
Purpose of the Study:
- To perform detailed electrophysiological characterization of highly pure hiPSC-derived cardiomyocytes.
- To compare their electrophysiological properties with human cardiac myocytes.
- To assess their suitability for high-throughput assays.
Main Methods:
- Perforated patch-clamp recordings of action potentials (APs) from spontaneously beating hiPSC-derived cardiomyocytes.
- Drug sensitivity assays using tetrodotoxin, nifedipine, and E4031.
- Gating properties analysis of seven key ionic currents (I(Na), I(Ca), I(f), I(to), I(K1), I(Kr), I(Ks)).
- Automated patch-clamp analysis enabled by high cell purity and numbers.
Main Results:
- Recorded APs exhibited atrial-, nodal-, and ventricular-like properties, with ventricular-like APs being most common.
- Ventricular-like APs showed maximum diastolic potentials and AP durations comparable to human cardiac myocytes.
- APs demonstrated expected drug sensitivities, and early afterdepolarizations (EADs) were inducible and dependent on bradycardia.
- Ionic currents and channel gating properties were quantitatively similar to human cardiac myocytes.
Conclusions:
- hiPSC-derived cardiomyocytes possess electrophysiological properties and ionic current characteristics comparable to human cardiac myocytes.
- These cells exhibit EADs, indicating potential for arrhythmogenesis studies.
- Their similarity to human cells, coupled with scalability for high-throughput assays, makes them a valuable tool for cardiovascular research and drug development.
Abstract:
Human-induced pluripotent stem cells (hiPSCs) can differentiate into functional cardiomyocytes; however, the electrophysiological properties of hiPSC-derived cardiomyocytes have yet to be fully characterized. We performed detailed electrophysiological characterization of highly pure hiPSC-derived cardiomyocytes. Action potentials (APs) were recorded from spontaneously beating cardiomyocytes using a perforated patch method and had atrial-, nodal-, and ventricular-like properties. Ventricular-like APs were more common and had maximum diastolic potentials close to those of human cardiac myocytes, AP durations were within the range of the normal human electrocardiographic QT interval, and APs showed expected sensitivity to multiple drugs (tetrodotoxin, nifedipine, and E4031). Early afterdepolarizations (EADs) were induced with E4031 and were bradycardia dependent, and EAD peak voltage varied inversely with the EAD take-off potential. Gating properties of seven ionic currents were studied including sodium (I(Na)), L-type calcium (I(Ca)), hyperpolarization-activated pacemaker (I(f)), transient outward potassium (I(to)), inward rectifier potassium (I(K1)), and the rapidly and slowly activating components of delayed rectifier potassium (I(Kr) and I(Ks), respectively) current. The high purity and large cell numbers also enabled automated patch-clamp analysis. We conclude that these hiPSC-derived cardiomyocytes have ionic currents and channel gating properties underlying their APs and EADs that are quantitatively similar to those reported for human cardiac myocytes. These hiPSC-derived cardiomyocytes have the added advantage that they can be used in high-throughput assays, and they have the potential to impact multiple areas of cardiovascular research and therapeutic applications.
More Related Videos
11:13Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)
Published on: May 12, 2017
08:39Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: December 22, 2020